Dennis J. Slamon
For the development of targeted therapy Herceptin against advanced breast cancer expressing the Her-2/Neu oncogene resulting in more effective therapy for breast cancer.
Recognition for work with lasting impact
For the development of targeted therapy Herceptin against advanced breast cancer expressing the Her-2/Neu oncogene resulting in more effective therapy for breast cancer.